BioWorld Today, Now a Part of Thomson Reuters

11 Followers

BioWorld Today delivers actionable intelligence on the biotech science that drives the business, which funds the means to heal disease. With writers and editors stationed around the globe, BioWorld Today reports the breaking news -- and provides key perspective -- on hundreds of medicines in development, the companies behind those therapeutic candidates, the business development transactions that evolve the market, and the regulatory hurdles that both challenge and guard the process.

biotechnology and pharmaceuticals biotechnology bioworld today thomson reuters biopharma biosimilars pharmaceutical industry pharmaceuticals fda bioworld clinical trial beth nuskey newport biosimilar andrew bourgoin analytics big data cortellis for informatics tim miller medical device medical equipment bio ind absorb trial virtual colonoscopy bill philips ge medicare abbott med-tech watchman data tomosynthesis med tech belviq jobs act qsymia btripla phentermine/topiramate fdasia hepatitis c bydureon linzess pdufa kalydeco lorcaserin vivus inc. obesity drugs erivedge xtandi arena pharmaceuticals inc. gain legislation cometriq marie powers david tiemeier university tto bioworld international bioworld insight edward lanphier ttos

Präsentationen
Dokumente
Infografiken

Aktuellste Beliebteste SlideShares

BioWorld Today, Now a Part of Thomson Reuters

Medical Device Daily - April 8, 2013

Biopharmaceutical Royalty Rates Analysis: Essential Benchmarks for Dealmaking (Preview)

BioWorld's Biotechnology State of the Industry Report 2011

BioWorld Executive Compensation Report 2013 (Preview)